Pharmaceutical Developments

Sober Living by the Sea has always been on a leader in the field of addiction treatment. You may have heard about some of the new drugs that have been developed to ease the process of recovery thus increasing the likelihood of success.

Sober Living by the Sea has consulting physicians on staff who can assess a client’s appropriateness and then prescribe and administer these new drugs. Of course, we believe that there is no substitute for a comprehensive residential treatment program.

Glossary:

Opiod: a term used to refer to opiate drugs (ie heroin and morphine) as well as synthetic narcotics (ie. demerol, oxycodone)

Receptor

Antagonist: this refers to a drug that binds to a receptor in your brain that would usually receive a narcotic. The result of taking a receptor antagonist is a reduced ability for a narcotic to interact with the receptors in your brain and thus less physical response to the narcotic.

Sold As (Brand Name):

Suboxone, Subutex

Vivitrol, Revia, Depade

Wellbrutrin, Zyban

Active Drug Ingredient: Buprenorphine Naltrexone Buproprion
Used For Treating: Opioid withdrawal and reduction of craving in early recovery Reduction of craving for alcohol and opioids Reduction of craving for smoking
How Administered: Via injection, transdermal patch, or sublingual tablet Oral tablet or occasional injection of slow release implant in abdomen Oral tablet- 12 hour slow release
Notes: Buprenorphine is an opiod receptor antagonist most commonly referred to by its brand name Suboxone.
This product is becoming more popular in the treatment of withdrawal from opioids and during the subsequent early recovery period. Suboxone is usually Administered by placing a tablet under the tongue, Suboxone will lessen the cravings of a opiate addicted person during withdrawal and during their early recovery.
Vivitrol is an opiod receptor antagonist most commonly used to reduce cravings
for alcohol in recovering individuals for up to 12 months.
By taking
a daily 50 mg tablet, individuals in test studies have proven to be
less likely to relapse. There is also a slow release Naltrexone implant
placed under the skin that dissolves over the course of 30 days.
Naltrexone is also occasionally used in the “rapid” detox of opiod
addicts during which it is administered while the individ-ual is under
general anesthesia.
Buproprion is a nicotinic antagonist that reduces cravings for smoking during the cessation process.
Initially
researched and marketed as an antidepressant (Wellbutrin), bupropion
was subsequently found to be effective as a smoking cessation aid and
then branded for this purpose with the name Zyban. Zyban is
administered for 7 to 12 weeks and the patient usually continues to
smoke for the first part of the treatment.
Side Effects: Headaches, dizziness, nausea, drowsiness Nausea, headache, dizziness, insomnia, drowsiness Dry mouth, nausea, insomnia, tremors
Warning: Not to be mixed with Benzodiazepines. Effectiveness is greatly enhanced when com-bined with an inpatient treatment program. Not
an acceptable substitute for a comprehensive treatment program that
includes testing, therapy, support groups, and addiction education.
Increases likelihood of seizures. It is possible to overdose on